Academic & Professional Portfolio
Previous Projects
This project was completed as part of my graduate coursework in Pharmaceutical Ethics and Intellectual Property Management during my M.S. in Pharmaceutical Science and Business at York College, CUNY. Working collaboratively, we developed a comprehensive regulatory and clinical development strategy for a hypothetical biologic therapy, Vodaxa, designed to treat steroid-resistant asthma. The project simulated the complete drug development process, from target identification and preclinical studies through IND preparation, clinical trial design, quality management, FDA review, and NDA submission.
I chose to showcase this project because it demonstrates my understanding of FDA regulatory pathways, clinical research, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), quality systems, and scientific communication. It also highlights my ability to apply regulatory principles to a realistic drug development scenario while collaborating on complex scientific and regulatory deliverables.
This presentation was completed as part of my graduate coursework in Advanced Pharmaceutics during my M.S. in Pharmaceutical Science and Business at York College, CUNY. The project critically evaluated the scientific literature on intranasal drug delivery for brain targeting, exploring how this non-invasive administration route can bypass the blood-brain barrier to improve drug delivery for central nervous system (CNS) disorders. The presentation examined the anatomy of the nasal cavity, mechanisms of nose-to-brain transport, preclinical and clinical research models, formulation strategies, and the advantages and limitations of intranasal drug delivery.
I chose to include this project because it demonstrates my ability to interpret and communicate complex pharmaceutical research, evaluate emerging drug delivery technologies, and translate scientific literature into clear, evidence-based presentations. It also highlights my understanding of pharmaceutics, drug formulation, preclinical development, and innovative approaches to overcoming challenges in CNS drug delivery.
This project was developed as part of my graduate studies in Pharmaceutical Science at York College, CUNY, where my team created a comprehensive Quality Control Validation Plan for the manufacturing of acetaminophen (N-(4-Hydroxyphenyl) Acetamide). The project followed current Good Manufacturing Practices (cGMP) and USP standards to design a complete quality control workflow, including incoming, in-process, and final product testing. We developed validation strategies and Standard Operating Procedures (SOPs) for analytical techniques such as HPLC, Differential Scanning Calorimetry (DSC), and dissolution testing, while incorporating equipment qualification, calibration procedures, documentation practices, and quality assurance requirements used throughout the pharmaceutical industry.
I chose to include this project because it demonstrates my understanding of pharmaceutical quality systems, analytical testing, process validation, and regulatory compliance. It highlights my ability to interpret USP standards, develop technical documentation, and apply cGMP principles to ensure product quality, safety, and consistency throughout the manufacturing process. These skills directly support careers in Regulatory Affairs, Quality Assurance, and Pharmaceutical Development.
This graduate capstone project was completed as part of my M.S. in Pharmaceutical Science and Business at York College, CUNY. The project consists of a comprehensive research paper and professional presentation examining the role of nanotechnology in lung cancer therapy, with a focus on emerging nanoparticle-based drug delivery systems and their potential to improve targeted cancer treatment. Through an extensive review of current scientific literature, I evaluated liposomes, polymeric nanoparticles, dendrimers, gold nanoparticles, and extracellular vesicles (EVs), while exploring FDA-approved nanomedicines, ongoing clinical trials, future innovations such as AI-guided nanocarrier design and CRISPR-based therapies, and the regulatory and ethical considerations associated with translating these technologies into clinical practice.
As the culminating project of my graduate program, this capstone allowed me to integrate advanced concepts in pharmaceutics, drug delivery, regulatory science, and scientific communication into a comprehensive analysis of an emerging area of pharmaceutical research. I chose to showcase this work because it demonstrates my ability to critically evaluate complex scientific literature, synthesize technical information into clear and evidence-based conclusions, and communicate scientific findings through both technical writing and professional presentations. These skills are directly applicable to careers in Regulatory Affairs, Medical Writing, Clinical Research, and pharmaceutical product development.